Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Edward G. Mansour"'
Autor:
Robert S. Witte, Allan J. Schutt, Edward Barylak, Jules E. Harris, Avital Cnaan, Edward G. Mansour
Publikováno v:
Cancer. 91:1020-1028
BACKGROUND The authors conducted a randomized Phase III trial of three treatment regimens for patients with residual, nonmeasurable, intra-abdominal metastatic disease after undergoing resection for primary colorectal carcinoma. METHODS To be eligibl
Publikováno v:
Surgery. 124:746-756
A univariate and multivariate statistical analysis of a single surgeon's experience with resectable malignant melanoma during 26 years (November 1970 to August 1996) was conducted.Six hundred twenty consecutive patients were registered. Univariate an
Publikováno v:
Cancer. 80:2333-2341
BACKGROUND The National Cancer Data Base (NCDB) represents a national electronic registry system now encompassing almost 60% of incident cancers in the United States. In combination with other programs of the American College of Surgeons Commission o
Autor:
Edward G. Mansour, Al B. Benson, Lynn M. Schuchter, Henry N. Wagner, Larry A. Otteman, Mark S. Talamonti, James A. Martenson, Stuart R. Lipsitz, Edward Kaplan
Publikováno v:
International Journal of Radiation OncologyBiologyPhysics. 35:745-749
Purpose : A prospective clinical trial was performed to assess the response and toxicity associated with the use of high dose radiation therapy, 5-fluorouracil, and cisplatin in patients with anal cancer. Methods and Materials : Patients with anal ca
Autor:
Kishan J. Pandya, Samuel G. Taylor, Donna Neuberg, Ömer Küçük, Harold O. Douglass, Daniel G. Haller, Edward G. Mansour, Al B. Benson, John L. Clark
Publikováno v:
American Journal of Clinical Oncology. 18:318-324
A phase II study was performed to determine the efficacy and toxicity of the etoposide, doxorubicin, cisplatin (EAP) regimen in the treatment of patients with advanced measurable gastric cancer in a multi-institutional cooperative group setting. Thir
Autor:
Edward G. Mansour
Publikováno v:
Cancer. 74:2672-2675
The role of clinical trials is becoming extremely important for our understanding of the effects of different therapeutic modalities of cancer treatment and the value of their interactions. Participation of patients in clinical trials remains disappo
Autor:
Thomas J. Smith, Edward G. Mansour, John Horton, Thomas E. Davis, J Wolter, Frank J. Cummings, Janet Andersen, Kenneth E. Gale, Douglass C. Tormey
Publikováno v:
Cancer. 73:354-361
Background. Tamoxifen and aminoglutethimide are two hormone therapies reported to be effective palliative approaches for patients with metastatic breast cancer. The current trial was designed to evaluate their relative therapeutic effectiveness. Meth
Autor:
Edward G. Mansour, Al B. Benson, Joshua K. Mondschein, James A. Martenson, Paul J. Catalano, Mark S. Talamonti, Henry N. Wagner, A. Bapsi Chakravarthy
Publikováno v:
International journal of radiation oncology, biology, physics. 81(4)
Purpose Although chemoradiation using 5-fluorouracil (5-FU) and mitomycin-C (MMC) is the standard of care in the treatment of anal cancer, many patients are unable to tolerate MMC. This Phase II clinical trial was performed to determine whether cispl
Autor:
CK Osborne, Kennedy W. Gilchrist, D. C. Allred, Martin D. Abeloff, Atul K. Tandon, Eudey L, Douglass C. Tormey, Gary M. Clark, Edward G. Mansour, R Molina
Publikováno v:
Journal of Clinical Oncology. 10:599-605
PURPOSE Amplification and/or overexpression of the HER-2/neu oncogene have been shown to correlate with poor clinical outcome in patients with axillary node-positive breast cancer. In contrast, the prognostic significance of HER-2/neu in node-negativ
Autor:
Diane Variakojis, Cheryl A. Arce, Hillard M. Lazarus, Martin M. Oken, Edward G. Mansour, Michael G. Chen, Dagmar Oette, Janet Andersen, Stanton L. Gerson
Publikováno v:
Blood. 78:830-837
Sixteen patients with relapsed non-Hodgkin's lymphoma underwent autologous bone marrow transplantation and infusion of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Treatment consisted of involved-field radiotherapy,